Lipoxygenase-inhibitory azomethines and benzoylhydrazones. I. Inhibition of the lipoxygenase activity and of the degranulation of mast cells in vitro by phenolic azomethines.
Bahr
T
T
Pharmakologische Forschungsgesellschaft, Biopharm GmbH Berlin.
Böhme
B
B
Ziska
T
T
Grupe
R
R
D000818:Animals; D001565:Benzoates / Q000737:chemistry / Q000494:pharmacology*; D003594:Cytoplasmic Granules / Q000187:drug effects / Q000502:physiology*; D007887:Fabaceae / Q000201:enzymology; D006636:Histamine Release / Q000187:drug effects; D006835:Hydrazones / Q000737:chemistry / Q000494:pharmacology*; D016859:Lipoxygenase Inhibitors; D008407:Mast Cells / Q000187:drug effects / Q000648:ultrastructure*; D015394:Molecular Structure; D017830:Octoxynol; D010529:Peritoneal Cavity / Q000166:cytology; D010946:Plants, Medicinal; D011092:Polyethylene Glycols / Q000494:pharmacology; D011479:Protamines / Q000494:pharmacology; D051381:Rats; D012545:Schiff Bases / Q000737:chemistry / Q000494:pharmacology*
D001565:Benzoates; D006835:Hydrazones; D016859:Lipoxygenase Inhibitors; D011479:Protamines; D012545:Schiff Bases; D011092:Polyethylene Glycols; D017830:Octoxynol